BCO2
gene geneOn this page
Also known as FLJ34464B-DIOX-II
Summary
BCO2 (beta-carotene oxygenase 2, HGNC:18503) is a protein-coding gene on chromosome 11q23.1, encoding Carotenoid-cleaving dioxygenase, mitochondrial (Q9BYV7). Broad specificity mitochondrial dioxygenase that mediates the asymmetric oxidative cleavage of carotenoids.
This gene encodes an enzyme which oxidizes carotenoids such as beta-carotene during the biosynthesis of vitamin A. Multiple transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 83875 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 89 total
- GTEx eGene: eQTL in 47 tissues, sQTL in 39 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.05 (unconstrained)
- MANE Select transcript:
NM_031938 - Notable: 89 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18503 |
| Approved symbol | BCO2 |
| Name | beta-carotene oxygenase 2 |
| Location | 11q23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ34464, B-DIOX-II |
| Ensembl gene | ENSG00000197580 |
| Ensembl biotype | protein_coding |
| OMIM | 611740 |
| Entrez | 83875 |
Gene structure
Transcript identifiers
Ensembl transcripts: 58 — 36 protein_coding, 15 nonsense_mediated_decay, 7 retained_intron
MANE Select: ENST00000357685
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 5, TSL 2: 6, TSL 3: 4, TSL 4: 2, TSL 5: 2
ENST00000357685, ENST00000361053, ENST00000438022, ENST00000460924, ENST00000461480, ENST00000494860, ENST00000525175, ENST00000526088, ENST00000527198, ENST00000527939, ENST00000530677, ENST00000531003, ENST00000531169, ENST00000532593, ENST00000532612, ENST00000532673, ENST00000532716, ENST00000534122, ENST00000534550, ENST00000856015, ENST00000856016, ENST00000856017, ENST00000856018, ENST00000856019, ENST00000856020, ENST00000856021, ENST00000856022, ENST00000856023, ENST00000856024, ENST00000856025, ENST00000856026, ENST00000856027, ENST00000958912, ENST00000958913, ENST00000958914, ENST00000958915, ENST00000958916, ENST00000958917, ENST00000958918, ENST00000958919, ENST00000958920, ENST00000958921, ENST00000974889, ENST00000974890, ENST00000974891, ENST00000974892, ENST00000974893, ENST00000974894, ENST00000974895, ENST00000974896, ENST00001029715, ENST00001029716, ENST00001029719, ENST00001029720, ENST00001029722, ENST00001029723, ENST00001122653, ENST00001142136
RefSeq mRNA: 5 — MANE Select: NM_031938
NM_001037290, NM_001256397, NM_001256398, NM_001256400, NM_031938
CCDS: CCDS41716, CCDS58181, CCDS58182, CCDS58183, CCDS8358
Canonical transcript exons
ENST00000357685 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001865060 | 112217761 | 112218946 |
| ENSE00002140404 | 112175512 | 112175689 |
| ENSE00003496031 | 112213724 | 112213861 |
| ENSE00003497402 | 112200613 | 112200773 |
| ENSE00003517751 | 112202023 | 112202190 |
| ENSE00003542671 | 112193879 | 112193994 |
| ENSE00003575644 | 112194653 | 112194755 |
| ENSE00003644131 | 112216220 | 112216330 |
| ENSE00003711640 | 112179278 | 112179482 |
| ENSE00003721487 | 112199699 | 112199827 |
| ENSE00003742170 | 112193474 | 112193697 |
| ENSE00003789952 | 112214762 | 112214944 |
Expression profiles
Bgee: expression breadth ubiquitous, 210 present calls, max score 97.25.
FANTOM5 (CAGE): breadth broad, TPM avg 2.4625 / max 163.2011, expressed in 469 samples.
Highest expression (Bgee): lobe of liver, apex of heart, ventricle myocardium, heart left ventricle, cardiac ventricle.
Genetic regulation across tissues (GTEx eQTL / sQTL)
BCO2 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 47 tissues and its splicing (sQTL) in 39 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 86 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Nerve Tibial | sqtl | 4.6e-95 | -1.28 | 11:112195020:CTATCT:C |
| Thyroid | sqtl | 6.1e-62 | -1.05 | 11:112210485:A:C |
| Heart Left Ventricle | eqtl | 4.3e-53 | -0.56 | 11:112210485:A:C |
| Adrenal Gland | eqtl | 8.3e-46 | -0.75 | 11:112210485:A:C |
| Pituitary | sqtl | 1.1e-44 | -1.45 | 11:112187553:C:T |
| Muscle Skeletal | eqtl | 2.3e-41 | -0.40 | 11:112210485:A:C |
| Heart Atrial Appendage | eqtl | 1.4e-39 | -0.54 | 11:112210485:A:C |
| Heart Atrial Appendage | sqtl | 4.3e-39 | -1.02 | 11:112210485:A:C |
| Adipose Subcutaneous | sqtl | 1.1e-34 | -0.84 | 11:112188554:C:T |
| Brain Cerebellum | sqtl | 1.0e-33 | -1.30 | 11:112199451:G:A |
| Thyroid | eqtl | 1.9e-33 | +0.47 | 11:112212373:C:T |
| Skin Not Sun Exposed Suprapubic | sqtl | 2.4e-33 | -0.89 | 11:112199451:G:A |
| Brain Cerebellar Hemisphere | sqtl | 1.8e-32 | -1.40 | 11:112199451:G:A |
| Testis | eqtl | 4.7e-32 | -0.44 | 11:112199451:G:A |
| Skin Sun Exposed Lower leg | eqtl | 1.1e-31 | +0.48 | 11:112194760:A:C |
| Esophagus Gastroesophageal Junction | sqtl | 3.2e-31 | -1.03 | 11:112210485:A:C |
| Brain Nucleus accumbens basal ganglia | sqtl | 1.6e-29 | -1.28 | 11:112187685:G:A |
| Colon Sigmoid | sqtl | 3.2e-29 | -1.11 | 11:112210485:A:C |
| Brain Nucleus accumbens basal ganglia | eqtl | 5.4e-28 | -0.65 | 11:112187685:G:A |
| Adipose Visceral Omentum | eqtl | 2.2e-27 | -0.30 | 11:112210485:A:C |
FANTOM5 promoters
3 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 116712 | 1.4488 | 354 |
| 116713 | 0.9368 | 305 |
| 116714 | 0.0769 | 33 |
Top tissues by expression
showing 100 of 248 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 97.25 | gold quality |
| apex of heart | UBERON:0002098 | 96.50 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 96.24 | gold quality |
| heart left ventricle | UBERON:0002084 | 96.02 | gold quality |
| cardiac ventricle | UBERON:0002082 | 95.83 | gold quality |
| right atrium auricular region | UBERON:0006631 | 95.80 | gold quality |
| cardiac atrium | UBERON:0002081 | 95.46 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.58 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.56 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.45 | gold quality |
| right uterine tube | UBERON:0001302 | 94.15 | gold quality |
| adrenal cortex | UBERON:0001235 | 93.08 | gold quality |
| heart | UBERON:0000948 | 93.01 | gold quality |
| liver | UBERON:0002107 | 92.47 | gold quality |
| myocardium | UBERON:0002349 | 92.19 | gold quality |
| adrenal gland | UBERON:0002369 | 92.14 | gold quality |
| adrenal tissue | UBERON:0018303 | 91.56 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 91.23 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 90.03 | gold quality |
| heart right ventricle | UBERON:0002080 | 89.65 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 89.15 | gold quality |
| oviduct epithelium | UBERON:0004804 | 88.70 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 87.05 | gold quality |
| hypothalamus | UBERON:0001898 | 86.09 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 85.84 | gold quality |
| adenohypophysis | UBERON:0002196 | 85.72 | gold quality |
| bronchial epithelial cell | CL:0002328 | 85.30 | gold quality |
| pituitary gland | UBERON:0000007 | 84.98 | gold quality |
| muscle of leg | UBERON:0001383 | 84.92 | gold quality |
| gall bladder | UBERON:0002110 | 84.77 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 84.73 | gold quality |
| bronchus | UBERON:0002185 | 84.32 | gold quality |
| gastrocnemius | UBERON:0001388 | 84.22 | gold quality |
| spinal cord | UBERON:0002240 | 83.86 | gold quality |
| caudate nucleus | UBERON:0001873 | 83.39 | gold quality |
| fallopian tube | UBERON:0003889 | 83.24 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.05 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.41 | gold quality |
| vagina | UBERON:0000996 | 82.15 | gold quality |
| substantia nigra | UBERON:0002038 | 82.09 | gold quality |
| muscle tissue | UBERON:0002385 | 82.01 | gold quality |
| biceps brachii | UBERON:0001507 | 81.64 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 81.63 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 81.61 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 81.54 | gold quality |
| corpus callosum | UBERON:0002336 | 81.44 | gold quality |
| putamen | UBERON:0001874 | 81.43 | gold quality |
| primary visual cortex | UBERON:0002436 | 81.14 | gold quality |
| right frontal lobe | UBERON:0002810 | 80.98 | gold quality |
| omental fat pad | UBERON:0010414 | 80.90 | gold quality |
| peritoneum | UBERON:0002358 | 80.86 | gold quality |
| esophagus mucosa | UBERON:0002469 | 80.81 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 80.74 | gold quality |
| tibial nerve | UBERON:0001323 | 80.58 | gold quality |
| midbrain | UBERON:0001891 | 80.16 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.08 | gold quality |
| body of uterus | UBERON:0009853 | 80.05 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 80.02 | gold quality |
| cerebellar cortex | UBERON:0002129 | 79.99 | gold quality |
| pancreatic ductal cell | CL:0002079 | 79.88 | silver quality |
| parietal pleura | UBERON:0002400 | 79.64 | gold quality |
| thyroid gland | UBERON:0002046 | 79.34 | gold quality |
| vastus lateralis | UBERON:0001379 | 79.31 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 79.29 | gold quality |
| quadriceps femoris | UBERON:0001377 | 79.24 | silver quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 79.21 | gold quality |
| endothelial cell | CL:0000115 | 79.06 | gold quality |
| metanephros cortex | UBERON:0010533 | 78.95 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 78.89 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 78.74 | gold quality |
| cerebellum | UBERON:0002037 | 78.64 | gold quality |
| deltoid | UBERON:0001476 | 78.56 | silver quality |
| esophagus | UBERON:0001043 | 78.44 | gold quality |
| right testis | UBERON:0004534 | 78.36 | gold quality |
| amygdala | UBERON:0001876 | 78.18 | gold quality |
| forebrain | UBERON:0001890 | 78.18 | gold quality |
| left testis | UBERON:0004533 | 78.05 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 77.99 | gold quality |
| ectocervix | UBERON:0012249 | 77.87 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 77.86 | gold quality |
| brain | UBERON:0000955 | 77.85 | gold quality |
| prefrontal cortex | UBERON:0000451 | 77.78 | gold quality |
| buccal mucosa cell | CL:0002336 | 77.75 | silver quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 77.73 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 77.71 | gold quality |
| sperm | CL:0000019 | 77.39 | silver quality |
| esophagus squamous epithelium | UBERON:0006920 | 77.28 | gold quality |
| endocervix | UBERON:0000458 | 77.11 | gold quality |
| cortex of kidney | UBERON:0001225 | 77.00 | gold quality |
| occipital lobe | UBERON:0002021 | 76.89 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 76.89 | gold quality |
| Ammon’s horn | UBERON:0001954 | 76.69 | gold quality |
| neocortex | UBERON:0001950 | 76.60 | gold quality |
| testis | UBERON:0000473 | 76.34 | gold quality |
| uterine cervix | UBERON:0000002 | 76.33 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.30 | gold quality |
| frontal cortex | UBERON:0001870 | 76.25 | gold quality |
| left uterine tube | UBERON:0001303 | 76.16 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.05 | gold quality |
| lower esophagus | UBERON:0013473 | 75.93 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-137537 | yes | 14.08 |
| E-ANND-3 | yes | 6.05 |
HPA expression
RNA tissue specificity: Tissue enhanced
showing 60 of 78 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Retina | tissue | 51.8 | high |
| Liver | tissue | 48.9 | medium |
| Heart muscle | tissue | 31.4 | not detected |
| Skeletal muscle | tissue | 20.1 | not detected |
| Choroid plexus | tissue | 19.1 | |
| Tongue | tissue | 13.3 | |
| Locus coeruleus | tissue | 12.6 | |
| Adrenal gland | tissue | 12.0 | medium |
| Postcentral gyrus | tissue | 10.1 | |
| Nucleus accumbens | tissue | 9.7 | |
| Fallopian tube | tissue | 9.1 | high |
| Hippocampus | tissue | 6.7 | not detected |
| Caudate putamen | tissue | 5.9 | |
| Frontal cortex | tissue | 5.2 | |
| Gallbladder | tissue | 4.8 | high |
| Vagina | tissue | 4.7 | not detected |
| Pituitary gland | tissue | 4.2 | |
| Periaqueductal gray | tissue | 4.0 | |
| Basal ganglia | tissue | 3.9 | not detected |
| Cerebral cortex | tissue | 3.7 | not detected |
| Amygdala | tissue | 3.7 | |
| Retrosplenial cortex | tissue | 3.7 | |
| Placenta | tissue | 3.6 | low |
| Substantia nigra | tissue | 3.6 | |
| Insular cortex | tissue | 3.6 | |
| Putamen | tissue | 3.5 | |
| Ventral forebrain | tissue | 3.5 | |
| Olfactory bulb | tissue | 3.4 | |
| Hippocampal formation | tissue | 3.3 | |
| Entorhinal cortex | tissue | 3.3 | |
| Temporal cortex | tissue | 3.3 | |
| Corpus callosum | tissue | 3.2 | |
| Hypothalamus | tissue | 3.1 | |
| Spinal cord | tissue | 3.1 | |
| Retrosplenial and cingulate cortex | tissue | 3.1 | |
| Occipital cortex | tissue | 3.0 | |
| Prefrontal cortex | tissue | 2.9 | |
| Midbrain | tissue | 2.9 | |
| Cerebellum | tissue | 2.9 | not detected |
| Septum | tissue | 2.9 | |
| Somatosensory cortex | tissue | 2.8 | |
| Motor cortex | tissue | 2.7 | |
| Medulla oblongata | tissue | 2.7 | |
| Thalamus | tissue | 2.6 | |
| Superior colliculi | tissue | 2.6 | |
| Pons | tissue | 2.1 | |
| Testis | tissue | 2.0 | low |
| Endometrium 1 | tissue | 1.4 | high |
| Esophagus | tissue | 1.3 | not detected |
| Urinary bladder | tissue | 1.3 | low |
| Thyroid gland | tissue | 1.3 | low |
| Lung | tissue | 1.2 | medium |
| Smooth muscle | tissue | 1.0 | not detected |
| Epididymis | tissue | 1.0 | high |
| Small intestine | tissue | 1.0 | high |
| Kidney | tissue | 1.0 | high |
| Skin 1 | tissue | 0.9 | not detected |
| Seminal vesicle | tissue | 0.8 | medium |
| Tonsil | tissue | 0.8 | medium |
| Pancreas | tissue | 0.7 | medium |
Brain sub-regions (HPA Brain Atlas): detected in 191; highest nTPM — Parieto-temporal junction (white matter) (14.5), Nucleus tractus solitarii (14.0), Corpus callosum, genu (white matter) (12.8), Periaquaductal grey, anterior (12.7), Principal sensory trigeminal nucleus (12.6).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting BCO2 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 82 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-4760-5P | 99.80 | 69.88 | 1619 |
| HSA-MIR-3913-5P | 99.78 | 67.26 | 968 |
| HSA-MIR-26A-5P | 99.78 | 73.52 | 2303 |
| HSA-MIR-26B-5P | 99.78 | 73.51 | 2305 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-556-3P | 99.74 | 68.75 | 1203 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-4465 | 99.71 | 72.56 | 2096 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
Functional genomics
gnomAD constraint: pLI 8.04e-13, LOEUF 1.05, missense Z 0.592 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000357685 — one region, missense o/e 0.97.
Literature-anchored findings (GeneRIF, showing 11)
- we found that the third family member, beta,beta-carotene-9’,10’-oxygenase (BCDO2), is a mitochondrial carotenoid-oxygenase with broad substrate specificity (PMID:21106934)
- The gene encoding beta-carotene-9’,10’-oxygenase, which cleaves the 9’,10’ double bond in beta-carotene into beta-apo-10’-carotenal, was cloned and expressed in Escherichia coli. (PMID:21302131)
- a stepwise cleavage by BCO2 and BCO1 with APO10ol as an intermediate could provide a mechanism to tailor asymmetric carotenoids such as beta-cryptoxanthin for vitamin A production. (PMID:24106281)
- Inactivity of human beta,beta-carotene-9’,10’-dioxygenase (BCO2) underlies retinal accumulation of the human macular carotenoid pigment. (PMID:24982131)
- Role of beta-Carotene 9,10-Dioxygenase in Macular Pigment Metabolism (PMID:26307071)
- review of molecular aspects in carotenoid metabolism and diseases (PMID:27390265)
- Study identifies BCO2 as a tumor suppressor in prostate cancer which mediates inhibition of NF-kB signaling. Its expression is decreased in human prostate cancer. (PMID:27406826)
- Associations for BCO2, PCSK9, and TR1B1 Polymorphism and Lifestyle Factors with Ischemic Stroke (PMID:31250580)
- Enzymology of vertebrate carotenoid oxygenases. (PMID:32035229)
- Evolutionary aspects and enzymology of metazoan carotenoid cleavage oxygenases. (PMID:32061750)
- The human mitochondrial enzyme BCO2 exhibits catalytic activity toward carotenoids and apocarotenoids. (PMID:32873706)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | bco2l | ENSDARG00000027620 |
| danio_rerio | bco2b | ENSDARG00000041715 |
| danio_rerio | bco2a | ENSDARG00000055722 |
| mus_musculus | Bco2 | ENSMUSG00000032066 |
| rattus_norvegicus | Bco2 | ENSRNOG00000038746 |
| drosophila_melanogaster | ninaB | FBGN0002937 |
Paralogs (2): RPE65 (ENSG00000116745), BCO1 (ENSG00000135697)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:2177469) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 13 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| abnormal adipose tissue morphology | 1 |
| abnormal liver morphology | 1 |
| enlarged spleen | 1 |
| small testis | 1 |
| abnormal homeostasis | 1 |
| decreased testis weight | 1 |
| decreased seminal vesicle weight | 1 |
| increased spleen weight | 1 |
| increased liver triglyceride level | 1 |
| abnormal blood homeostasis | 1 |
| abnormal hepatocyte physiology | 1 |
| abnormal aerobic respiration | 1 |
| macrovesicular hepatic steatosis | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Chlorocebus aethiops | Q9XT71 | 99.6% | Diamond |
| Bos taurus | Q28175 | 98.7% | Diamond |
| Canis lupus familiaris | Q9TVB8 | 98.5% | Diamond |
| Pongo abelii | Q5RF16 | 98.0% | Diamond |
| Macaca fascicularis | Q8HXG8 | 95.5% | Diamond |
| Cynops pyrrhogaster | Q8AXN9 | 92.5% | Diamond |
| Ambystoma tigrinum | Q9YI25 | 92.5% | Diamond |
| Gallus gallus | Q9YGX2 | 90.6% | Diamond |
| Mustela putorius furo | Q6QT07 | 84.5% | Diamond |
| Arabidopsis thaliana | Q8VY26 | 65.4% | Diamond |
| Galleria mellonella | A8Y9I2 | 49.1% | Diamond |
| Fusarium fujikuroi IMI 58289 | S0ENQ2 | 43.0% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| PLET1 | protein-coding | 349633 |
| PTS | protein-coding | 5805 |
| TEX12-AS1 | ncRNA | 107987164 |
| TEX12 | protein-coding | 56158 |
| IL18 | protein-coding | 3606 |
| SDHD | protein-coding | 6392 |
Protein
Protein identifiers
Carotenoid-cleaving dioxygenase, mitochondrial — Q9BYV7 (reviewed: Q9BYV7)
Alternative names: B-diox-II, Beta,beta-carotene 9’,10’-oxygenase, Beta-carotene dioxygenase 2
All UniProt accessions (6): E9PPP9, E9PS89, Q9BYV7, H0YCL7, H0YCN8, V9GYA9
UniProt curated annotations — full annotation on UniProt →
Function. Broad specificity mitochondrial dioxygenase that mediates the asymmetric oxidative cleavage of carotenoids. Cleaves carotenes (pure hydrocarbon carotenoids) such as all-trans-beta-carotene and lycopene as well as xanthophylls (oxygenated carotenoids) such as zeaxanthin, lutein and beta-cryptoxanthin at both the 9,10 and the 9’,10’ carbon-carbon double bond. Through its function in carotenoids metabolism regulates oxidative stress and the production of important signaling molecules.
Subcellular location. Mitochondrion.
Tissue specificity. Highly expressed in retinal pigment epithelium. Also expressed in stomach, small intestine, liver, testis, kidney, adrenal gland, pancreas, heart, skeletal muscle and prostate (at protein level).
Cofactor. Binds 1 Fe(2+) ion per subunit.
Similarity. Belongs to the carotenoid oxygenase family.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BYV7-1 | 1 | yes |
| Q9BYV7-2 | 2 | |
| Q9BYV7-4 | 4 | |
| Q9BYV7-5 | 5 | |
| Q9BYV7-6 | 6 |
RefSeq proteins (5): NP_001032367, NP_001243326, NP_001243327, NP_001243329, NP_114144* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004294 | Carotenoid_Oase | Family |
Pfam: PF03055
Enzyme classification (BRENDA)
- EC 1.13.11.71 — carotenoid-9’,10’-cleaving dioxygenase (BRENDA: 11 organisms, 24 substrates, 6 inhibitors, 5 Km, 4 kcat entries)
Substrate kinetics (BRENDA)
4 substrates with measured Km, best-characterized 4. Km ranges are aggregated across organisms/conditions.
| Substrate | Km (mM) | Measurements |
|---|---|---|
| BETA-CAROTENE | 0.0152–0.067 | 2 |
| ALL-TRANS-BETA-CAROTENE | 0.037 | 1 |
| ALPHA-CAROTENE | 0.048 | 1 |
| LUTEIN | 0.105 | 1 |
Catalyzed reactions (Rhea)
- all-trans-beta-carotene + O2 = beta-ionone + all-trans-10’-apo-beta-carotenal (RHEA:26389)
- all-trans-zeaxanthin + 2 O2 = 4,9-dimethyldodeca-2,4,6,8,10-pentaenedial + 2 (3R)-hydroxy-beta-ionone (RHEA:26393)
- all-trans-zeaxanthin + O2 = (3R)-3-hydroxy-10’-apo-beta-carotenal + (3R)-hydroxy-beta-ionone (RHEA:68104)
- (3R)-3-hydroxy-10’-apo-beta-carotenal + O2 = 4,9-dimethyldodeca-2,4,6,8,10-pentaenedial + (3R)-hydroxy-beta-ionone (RHEA:68424)
- lutein + O2 = (3R,6R)-hydroxy-alpha-ionone + (3R)-3-hydroxy-10’-apo-beta-carotenal (RHEA:68428)
- lutein + O2 = (3R,6R)-3-hydroxy-10’-apo-alpha-carotenal + (3R)-hydroxy-beta-ionone (RHEA:68432)
- (3R,6R)-3-hydroxy-10’-apo-alpha-carotenal + O2 = (3R,6R)-hydroxy-alpha-ionone + 4,9-dimethyldodeca-2,4,6,8,10-pentaenedial (RHEA:68436)
- beta-cryptoxanthin + O2 = all-trans-10’-apo-beta-carotenal + (3R)-hydroxy-beta-ionone (RHEA:68440)
- 5-cis-lycopene + O2 = 5-cis-10’-apo-lycopenal + (3E,5E)-6,10-dimethylundeca-3,5,9-trien-2-one (RHEA:68444)
- 13-cis-lycopene + O2 = 13-cis-10’-apo-lycopenal + (3E,5E)-6,10-dimethylundeca-3,5,9-trien-2-one (RHEA:68448)
- all-trans-10’-apo-beta-carotenal + O2 = beta-ionone + 4,9-dimethyldodeca-2,4,6,8,10-pentaenedial (RHEA:68452)
UniProt features (17 total): sequence conflict 5, binding site 4, splice variant 4, sequence variant 3, chain 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYV7-F1 | 88.41 | 0.78 |
Human Protein Atlas
Protein class: Enzymes, ENZYME proteins, Oxidoreductases, Metabolic proteins, Predicted intracellular proteins
Protein evidence: Evidence at protein level
Antibody reliability (HPA): IH supported
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (4)
| Position | Role |
|---|---|
| 226 | Fe cation |
| 286 | Fe cation |
| 357 | Fe cation |
| 573 | Fe cation |
Function
Pathways and Gene Ontology
Reactome pathways
1 curated (TAS) of 6; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
6 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-975634 | Retinoid metabolism and transport | curated |
| R-HSA-1430728 | Metabolism | — |
| R-HSA-6806667 | Metabolism of fat-soluble vitamins | — |
| R-HSA-196854 | Metabolism of vitamins and cofactors | — |
| R-HSA-9709957 | Sensory Perception | — |
| R-HSA-2187338 | Visual phototransduction | — |
MSigDB gene sets: 141 (showing top):
SHEPARD_BMYB_MORPHOLINO_UP, ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS, GOBP_RETINAL_METABOLIC_PROCESS, GOBP_RETINOIC_ACID_METABOLIC_PROCESS, GOBP_LIPID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, GOBP_ALDEHYDE_METABOLIC_PROCESS, GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, MCCABE_HOXC6_TARGETS_CANCER_UP, GOBP_LIPID_CATABOLIC_PROCESS
GO Biological Process (12): carotenoid metabolic process (GO:0016116), carotene metabolic process (GO:0016119), carotene catabolic process (GO:0016121), xanthophyll catabolic process (GO:0016124), retinoic acid metabolic process (GO:0042573), retinal metabolic process (GO:0042574), regulation of mitochondrial membrane potential (GO:0051881), lutein catabolic process (GO:0062172), lycopene catabolic process (GO:1901176), zeaxanthin catabolic process (GO:1901826), regulation of reactive oxygen species metabolic process (GO:2000377), lipid metabolic process (GO:0006629)
GO Molecular Function (8): beta-carotene 15,15’-dioxygenase activity (GO:0003834), carotenoid dioxygenase activity (GO:0010436), 9,10 (9’, 10’)-carotenoid-cleaving dioxygenase activity (GO:0010437), oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702), metal ion binding (GO:0046872), beta,beta-carotene-9’,10’-cleaving oxygenase activity (GO:0102076), oxidoreductase activity (GO:0016491), dioxygenase activity (GO:0051213)
GO Cellular Component (2): mitochondrion (GO:0005739), mitochondrial matrix (GO:0005759)
Reactome top-level categories
5 top-level categories:
| Category | Pathways |
|---|---|
| Visual phototransduction | 1 |
| Metabolism of fat-soluble vitamins | 1 |
| Metabolism | 1 |
| Sensory Perception | 1 |
| Metabolism of vitamins and cofactors | 1 |
GO top-level categories
28 GO namespaces:
| Category | Terms |
|---|---|
| oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 3 |
| retinoid metabolic process | 2 |
| xanthophyll catabolic process | 2 |
| terpenoid metabolic process | 1 |
| terpene metabolic process | 1 |
| carotene metabolic process | 1 |
| terpene catabolic process | 1 |
| carotenoid catabolic process | 1 |
| xanthophyll metabolic process | 1 |
| monocarboxylic acid metabolic process | 1 |
| hormone metabolic process | 1 |
| aldehyde metabolic process | 1 |
| olefinic compound metabolic process | 1 |
| regulation of membrane potential | 1 |
| carotene catabolic process | 1 |
| regulation of metabolic process | 1 |
| reactive oxygen species metabolic process | 1 |
| primary metabolic process | 1 |
| carotenoid dioxygenase activity | 1 |
| oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 1 |
| dioxygenase activity | 1 |
| cation binding | 1 |
| catalytic activity | 1 |
| oxidoreductase activity | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| mitochondrion | 1 |
| intracellular organelle lumen | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 3 of 22 annotations. The rest are phylogenetic / computational / electronic (IEA).
3 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| carotene catabolic process | BP | direct assay |
| carotene metabolic process | BP | direct assay |
| oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | MF | direct assay |
Protein interactions and networks
STRING
showing 15 of 702 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BCO2 | STARD3 | Q14849 | 648 |
| BCO2 | ISX | Q2M1V0 | 644 |
| BCO2 | ASIP | P42127 | 571 |
| BCO2 | RARS1 | P54136 | 569 |
| BCO2 | LRAT | O95237 | 559 |
| BCO2 | SCARB1 | Q8WTV0 | 545 |
| BCO2 | GSTP1 | P09211 | 504 |
| BCO2 | RDH14 | Q9HBH5 | 497 |
| BCO2 | RDH13 | Q8NBN7 | 496 |
| BCO2 | CYP26A1 | O43174 | 462 |
| BCO2 | SPR | P35270 | 461 |
| BCO2 | MITF | O75030 | 454 |
| BCO2 | MC1R | Q01726 | 453 |
| BCO2 | RDH10 | Q8IZV5 | 451 |
| BCO2 | STRA6 | Q9BX79 | 441 |
IntAct
BioGRID (2 interactions; top human partners by supporting records): DPF3 (Cross-Linking-MS (XL-MS)), NUDT1 (Cross-Linking-MS (XL-MS))
Disease & clinical
Genetic variants
Variant evidence for BCO2: 89 ClinVar records (0 pathogenic / likely pathogenic); 5 GWAS associations.
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 74 |
| Likely benign | 9 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 27 predictions of 1,284):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 11:112177595 | donor_gain | 1.0000 | |
| 11:112179479 | donor_gain | 1.0000 | |
| 11:112200784 | donor_gain | 1.0000 | |
| 11:112202021–112202022 | acceptor_loss | 1.0000 | 6 |
| 11:112202167 | donor_gain | 1.0000 | |
| 11:112202191–112202192 | donor_loss | 1.0000 | 5 |
| 11:112216209 | acceptor_gain | 1.0000 | |
| 11:112216331–112216332 | donor_loss | 1.0000 | 5 |
| 11:112217759–112217760 | acceptor_loss | 1.0000 | 5 |
| 11:112177603 | donor_gain | 0.9900 |
AlphaMissense
974 missense substitutions predicted likely pathogenic (of 3,835 scored), across 279 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| D104 | 8 | 0.972 | 0.988 |
| D371 | 8 | 0.967 | 0.981 |
| H286 | 8 | 0.946 | 0.982 |
| H357 | 8 | 0.930 | 0.981 |
| H573 | 8 | 0.930 | 0.981 |
| H226 | 8 | 0.926 | 0.981 |
| F103 | 8 | 0.909 | 0.980 |
| F288 | 8 | 0.905 | 0.987 |
| D176 | 8 | 0.880 | 0.973 |
| H101 | 8 | 0.852 | 0.952 |
| W325 | 7 | 0.933 | 0.982 |
| F411 | 7 | 0.929 | 0.984 |
| N177 | 7 | 0.924 | 0.985 |
| R410 | 7 | 0.923 | 0.979 |
| F92 | 7 | 0.915 | 0.975 |
| W507 | 7 | 0.908 | 0.954 |
| F125 | 7 | 0.894 | 0.970 |
| F145 | 7 | 0.889 | 0.973 |
| F519 | 7 | 0.880 | 0.954 |
| F333 | 7 | 0.876 | 0.992 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Kidney Chromophobe)
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
2 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Liver Hepatocellular Carcinoma (validation) | favorable | 6.24e-06 |
| Pancreatic Adenocarcinoma (validation) | unfavorable | 0.000866 |
Disease associations
OMIM: gene MIM:611740 | disease phenotypes:
GWAS associations
5 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST002255_1 | Inflammatory biomarkers | 2e-32 |
| GCST009736_1 | Interleukin-18 levels | 2e-32 |
| GCST000590_1 | Interleukin-18 levels | 4e-9 |
| GCST000590_2 | Interleukin-18 levels | 1e-8 |
| GCST001537_1 | Immune reponse to smallpox (secreted IL-12p40) | 1e-8 |
EFO canonical traits (from GWAS)
4 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0004581 | interleukin 18 measurement |
| EFO:0004645 | response to vaccine |
| EFO:0004873 | cytokine measurement |
| EFO:0004812 | interleukin-1 beta measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | decreases expression | 2 |
| sotorasib | decreases expression, affects cotreatment | 1 |
| methylmercuric chloride | decreases expression | 1 |
| propionaldehyde | increases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| abrine | decreases expression | 1 |
| bisphenol S | increases methylation | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| trametinib | affects cotreatment, decreases expression | 1 |
| NVP-BKM120 | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | increases expression | 1 |
| Succimer | affects cotreatment, decreases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | decreases expression | 1 |
| Magnetite Nanoparticles | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
1 trials:
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT05257005 | Not specified | UNKNOWN | Natural History Study of Pyruvate Dehydrogenase Deficiency |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.